Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013

Alzheimer's and Dementia

Volumn 13, Issue 1, 2017, Pages 28-37

  Goodman, Richard A ^a,b   Lochner, Kimberly A ^c   Thambisetty, Madhav ^d   Wingo, Thomas S ^b,e   Posner, Samuel F ^a   Ling, Shari M ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Dementia; Epidemiology; Medicare; Prevalence; Subtypes

Indexed keywords

AGED; ALASKA NATIVE; ALCOHOL INDUCED DEMENTIA; ALCOHOLISM; ALZHEIMER DISEASE; AMERICAN INDIAN; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MULTIINFARCT DEMENTIA; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SEX RATIO; UNITED STATES; VERY ELDERLY; ADULT; AGE DISTRIBUTION; CLASSIFICATION; ECONOMICS; MEDICAL FEE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DEMENTIA; FEE-FOR-SERVICE PLANS; FEMALE; HUMANS; MALE; MEDICARE; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84977627614     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.04.002     Document Type: Article

References (50)

1. [1] Alzheimer's Association. 2015 Alzheimer's disease facts and figures. Alzheimers Dement, 11, 2015, 332.
2. [2] Brookmeyer, R., Gray, S., Kawas, C., Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88 (1998), 1337–1342.
3. [3] Rice, D.P., Fox, P.J., Max, W., Webber, P.A., Lindeman, D.A., Hauck, W.W., et al. The economic burden of Alzheimer's disease care. Health Aff 12 (1993), 164–176.
4. [4] Sloane, P.D., Zimmerman, S., Suchindran, C., Reed, P., Wang, L., Boustani, M., et al. The public health impact of Alzheimer's Disease, 2000-2050: potential implication of treatment advances. Ann Rev Public Health 23 (2002), 213–231.
5. [5] Office of the Assistant Secretary for Planning and Evaluation. National Alzheimer's Project Act. Available at: http://aspe.hhs.gov/national-alzheimers-project-act. Accessed December 30, 2015.
6. [6] Alzheimer's Association National Plan Care and Support Milestone Workgroup, Borson, S., Boustani, M.A., Buckwalter, K.C., Burgio, L.D., Chodosh, J., Fortinsky, R.H., et al. Report on milestones for care and support under the U.S. National Plan to Address Alzheimer's Disease. Alzheimers Dement 12 (2016), 334–369.
7. [7] Hebert, L.E., Weuve, J., Scherr, P.A., Evans, D.A., Alzheimer disease in the United States (2010-2050) estimated using the 2010 Census. Neurology 80 (2013), 1778–1783.
8. [8] Plassman, B.L., Langa, K.M., Fisher, G.G., Heeringa, S.G., Weir, D.R., Ofstedal, M.B., et al. Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology 29 (2007), 125–132.
9. [9] Knopman, D.S., Roberts, R.O., Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci 45 (2011), 330–335.
10. [10] Savica, R., Grossardt, B.R., Bower, J.H., Boeve, B.F., Ahlskog, J., Rocca, W.A., Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol 70 (2013), 1396–1402.
11. [11] Lin, P.J., Kaufer, D.I., Maciejewski, M.L., Ganguly, R., Paul, J.E., Biddle, A.K., An examination of Alzheimer's disease case definitions using Medicare claims and survey data. Alzheimers Dement 6 (2010), 334–341.
12. [12] Nagy, Z., Esiri, M.M., Hindley, N.J., Joachim, C., Morris, J.H., King, E.M., et al. Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dement Geriatr Cogn Disord 9 (1998), 219–226.
13. [13] Newcomer, R., Clay, T., Luxenberg, J.S., Miller, R.H., Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc 47 (1999), 215–219.
14. [14] Pressley, J.C., Trott, C., Tang, M., Durkin, M., Stern, Y., Dementia in community-dwelling elderly patients: a comparison of survey data, Medicare claims, cognitive screening, reported symptoms, and activity limitations. J Clin Epidemiol 56 (2003), 896–905.
15. [15] Ostbye, T., Taylor, D.H., Clipp, E.C., Scoyoc, L.V., Plassman, B.L., Identification of dementia: agreement among national survey data, Medicare claims, and death certificates. Health Serv Res 43:1 Pt 1 (2008), 313–326.
16. [16] Taylor, D.H., Ostbye, T., Langa, K.M., Weir, D., Plassman, B.L., The accuracy of claims as an epidemiological tool: the case of dementia revisited. J Alzheimers Dis 17 (2009), 807–815.
17. [17] Centers for Medicare and Medicaid Services. Chronic Condition Data Warehouse. Available at: https://www.ccwdata.org/web/guest/condition-categorieshttp://www.ccwdata.org/index.htm. Accessed December 30, 2015.
18. [18] Centers for Medicare & Medicaid Services. What's Medicare? Available at: https://www.medicare.gov/sign-up-change-plans/decide-how-to-get-medicare/whats-medicare/what-is-medicare.html. Accessed March 10, 2016.
19. [19] Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HUCP). Clinical Classifications Software for ICD-9-CM. November 2015, Agency for Healthcare Research and Quality, Rockville, MD Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp Accessed December 30, 2015.
20. [20] Taylor, D.H., Fillenbaum, G.G., Ezell, M.E., The accuracy of Medicare claims data in identifying Alzheimer's disease. J Clin Epidemiol 55 (2002), 929–937.
21. [21] Mielke, M.M., Vemuri, P., Rocca, W.A., Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol 6 (2014), 37–48.
22. [22] Bienias, J.L., Beckett, L.A., Bennett, D.A., Wilson, R.S., Evans, D.A., Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis 5 (2003), 349–355.
23. [23] Brookmeyer, R., Evans, D.A., Hebert, L., Langa, K.M., Heeringa, S.G., Plassman, B.L., et al. National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement 7 (2011), 61–73.
24. [24] Evans, D.A., Bennett, D.A., Wilson, R.S., Bienias, J.L., Morris, M.C., Scherr, P.A., et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol 60 (2003), 185–189.
25. [25] Langa, K.M., Plassman, B.L., Wallace, R.B., Herzog, A.R., Heeringa, S.G., Ofstedal, M.B., et al. The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology 25 (2005), 181–191.
26. [26] Mayeux, R., Stern, Y., Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med, 2, 2012.
27. [27] Reitz, C., Brayne, C., Mayeux, R., Epidemiology of Alzheimer disease. Nat Rev Neurol 7 (2011), 137–152.
28. [28] Sosa-Ortiz, A.L., Acosta-Castillo, I., Prince, M.J., Epidemiology of dementias and Alzheimer's disease. Arch Med Res 43 (2012), 600–608.
29. [29] Butler, D., Kowall, N.W., Lawler, E., Gaziano, J.M., Driver, J.A., Underuse of diagnostic codes for specific dementias in the Veterans Affairs New England Healthcare System. J Am Geriatr Soc 60 (2012), 910–915.
30. [30] O'Brien, J.T., Thomas, A., Vascular dementia. Lancet 386 (2015), 1698–1706.
31. [31] Allan, L.M., Rowan, E.N., Firbank, M.J., Thomas, A.J., Parry, S.W., Polvikoski, T.M., et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 134 (2011), 3713–3724.
32. [32] Pendlebury, S.T., Rothwell, P.M., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8 (2009), 1006–1018.
33. [33] Onyike, C.U., Diehl-Schmid, J., The epidemiology of frontotemporal dementia. Int Rev Psychiatry 25 (2013), 130–137.
34. [34] Mercy, L., Hodges, J.R., Dawson, K., Barker, R.A., Brayne, C., Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 71 (2008), 1496–1499.
35. [35] Ridley, N., Draper, B., Withall, A., Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther, 5, 2013, 3.
36. [36] Hogervorst, E., Bandelow, S., Combrinck, M., Irani, S.R., Smith, A.D., The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach. Dement Geriatr Cogn Disord 16 (2003), 170–180.
37. [37] Holmes, C., Cairns, N., Lantos, P., Mann, A., Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174 (1999), 45–50.
38. [38] Jellinger, K.A., Commentary on “Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples”. Alzheimers Dement 2 (2006), 169–170.
39. [39] Plassman, B.L., Khachatruian, A.S., Townsend, J.J., Ball, M.J., Steffens, D.C., Leslie, C.E., et al. Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples. Alzheimers Dement 2 (2006), 2–11.
40. [40] Price, J.L., McKeel, D.W. Jr., Buckles, V.D., Roe, C.M., Xiong, C., Grundman, M., et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30 (2009), 1026–1036.
41. [41] Williams, J.B.W., American Psychiatric Association. Diagnostic criteria from DSM-III-R. 1987, American Psychiatric Association, Washington, DC.
42. [42] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984), 939–944.
43. [43] McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 263–269.
44. [44] Borson, S., Scanlan, J., Hummel, J., Gibbs, K., Lessig, M., Zuhr, E., Implementing routine cognitive screening of older adults in primary care: process and impact on physician behavior. J Gen Intern Med 22 (2007), 811–817.
45. [45] National Guideline Clearinghouse (NGC). Guideline summary: Dementia. Diagnosis and treatment. In: National Guideline Clearinghouse (NGC) [ www.guideline.gov/index.aspx]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); [cited 2015 Dec 7]. Available at: http://www.guideline.gov/content.aspx?id=32599. Accessed December 30, 2015.
46. [46] Cordell, C.B., Borson, S., Boustani, M., Chodosh, J., Reuben, D., Verghese, J., et al., Medicare Detection of Cognitive Impairment Workgroup. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement 9 (2013), 141–150.
47. [47] Centers for Medicare & Medicaid Services. Medicare & Medicaid Statistical Supplement, 2013 Edition, Table 2.2. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareMedicaidStatSupp/2013.html. Accessed December 30, 2015.
48. [48] US Department of Health and Human Services. Dementias, including Alzheimer's disease. Healthy People 2020. Available at: http://www.healthypeople.gov/2020/topics-objectives/topic/dementias-including-alzheimers-disease. Accessed December 30, 2015.
49. [49] US Department of Health and Human Services. Natl Plan Address Alzheimer's Dis: 2015 Update. Available at: http://aspe.hhs.gov/sites/default/files/pdf/107031/NatlPlan2015.pdf. Accessed December 30, 2015.
50. [50] Montine, T., Alzheimer's disease-related dementias: conference and recommendations report to the NINDS Council. 2013 Available at: http://www.ninds.nih.gov/funding/areas/neurodegeneration/workshops/adrd2013/ Accessed December 30, 2015.